IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q4 2014 Holdings

Filed 2015-02-17 | 31 holdings | $20.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$19.6M2,443,10097.5%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$78.0K5,093,8100.4%
Chemocentryx Inc(CCXIEUR)COM16383L106$58.7K8,596,7720.3%
Array Biopharma Inc(ARRYEUR)COM04269X105$55.7K11,772,3350.3%
Ligand Pharmaceuticals Inc(LGND)COM NEW53220K504$45.8K860,0630.2%
Oncomed Pharmaceuticals IncCOM68234X102$29.9K1,374,8150.1%
Oncothyreon IncCOM682324108$26.1K13,762,2600.1%
Five Prime Therapeutics Inc(FPRX)COM33830X104$22.3K826,3320.1%
Forward Pharma A/SSPONSORED ADR34986J105$21.9K1,052,3810.1%
Exelixis IncNOTE 4.250% 8/130161QAC8$18.1K$31,239,0000.1%
Targacept IncCOM87611R306$17.5K6,655,1280.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$16.1K1,206,4590.1%
Loxo Oncology IncCOM548862101$14.0K1,190,7020.1%
Vitae Pharmaceuticals IncCOM92847N103$12.5K753,9350.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$12.2K618,2240.1%
QLT IncCOM746927102$10.6K2,650,5630.1%
Array Biopharma IncNOTE 3.000% 06/004269XAA3$8.5K$9,000,0000.0%
GTX Inc delCOM40052B108$8.1K11,111,1110.0%
Sunesis Pharmaceuticals IncCOM NEW867328601$8.0K3,136,0000.0%
Exelixis Inc(EXEL)COM30161Q104$6.0K4,195,3520.0%
Arqule Inc(ARQLUSD)COM04269E107$5.8K4,723,8110.0%
Mast Therapeutics IncCOM576314108$4.1K7,291,6000.0%
Oncogenex Pharmaceuticals inCOM68230A106$3.1K1,368,5000.0%
Biolinerx LTDSPONSORED ADR09071M106$2.4K1,501,0000.0%
Kalobios Pharmaceuticals IncCOM48344T100$2.0K1,162,0000.0%
Achaogen IncCOM004449104$1.8K136,6000.0%
Regado Biosciences IncCOM75874Q107$1.7K1,882,5210.0%
Aptose Biosciences IncCOM NEW03835T200$986166,6640.0%
Biota Pharmaceutials IncCOM090694100$976435,9000.0%
Anthera Pharmaceuticals IncCOM NEW03674U201$884559,6240.0%
Sophiris BIO IncCOM NEW83578Q209$5731,060,2830.0%